NCT01703052View on ClinicalTrials.gov

Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV)

PHASE1CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

CHF 6001 SD or placebo

Dry Powder Inhaler

DRUG

CHF 6001 MD or placebo

Dry Powder Inhaler

Trial Locations (1)

Unknown

Quotient Clinical, Nottingham

All Listed Sponsors
lead

Chiesi Farmaceutici S.p.A.

INDUSTRY

NCT01703052 - Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers (HV) | Biotech Hunter | Biotech Hunter